Study concludes that few of the associated risk factors are modifiable and that clinicians should stress possible outcomes related to urinary dysfunction prior to patients receiving treatment for rectal cancer.
No significantly lower composite prolapse outcome found for vaginal hysteropexy versus vaginal hysterectomy
In a study, investigators did not observe a clinically important difference between midurethral sling surgery patients who did and did not receive perioperative behavioral therapies.
Proportion of apical procedures using transvaginal mesh decreased in year after safety communication
After a mean 9 years of follow-up, women who underwent tension-free vaginal tape obturator surgery for stress urinary incontinence had objective and subjective cure rates of 89% and 92%, respectively, a study found.
In a study, women undergoing a transobturator sling procedure had a 2.4-fold higher risk of reoperation for recurrent stress urinary incontinence than those undergoing a retropubic sling procedure.
The FDA has approved ProVate (ConTIPI) for the temporary, nonsurgical management of pelvic organ prolapse in women.
An over-the-counter device to treat stress urinary incontinence (SUI) in women has been made available by Rinovum Women’s Health.
The agency alleges manufacturers failed to provide evidence of the long-term safety of surgical mesh for transvaginal repair of anterior compartment prolapse.
Behavioral therapies relieve stress, urgency, and mixed urinary incontinence (UI) more effectively than drug monotherapies in nonpregnant women. In a new systematic review and network meta-analysis (NMA) of 84 randomized trials published in the Annals of Internal Medicine, most interventions including combination therapies improved or resolved women’s symptoms better than no treatment, whether sham or…